Literature DB >> 12539890

Association of symptoms and convergence and accommodative insufficiency in school-age children.

Eric Borsting1, Michael W Rouse, Paul N Deland, Steve Hovett, Dan Kimura, Mark Park, Brian Stephens.   

Abstract

BACKGROUND: The purpose of this article was to investigate the association between convergence insufficiency (CI) and accommodative insufficiency (AI) and symptoms in a group of school-aged children.
METHODS: Children ages 8 to 15 years were recruited from two public and 2 private elementary schools in Southern California. The CI Symptom Survey (CISS) was administered to all children before a Modified Clinical Technique vision screening. Children with normal visual acuity, minimal uncorrected refractive error, and no strabismus were tested for CI and Al.
RESULTS: Four hundred sixty nine children were initially screened and 392 participated in testing for CI and AI. Fifty-five percent of the children (218) were classified as having normal binocular vision (NBV), 4.6% (18) had three signs of CI, 12.7% (50) had two signs of CI, 10.5% (41) were classified as AI (with no signs of CI), and 16.6% (65) were classified as other. The symptom score was 3.78 for the NBV group, 4.6 for the two-sign CI group, 6.67 for the three-sign CI group, and 6.37 for the Al group. The three-sign CI and the Al groups scored significantly higher than the NBV group on the CISS (p < or = 0.001).
CONCLUSION: CI and AI are common conditions in school-age children and are associated with increased symptoms.

Entities:  

Mesh:

Year:  2003        PMID: 12539890

Source DB:  PubMed          Journal:  Optometry        ISSN: 1558-1527


  57 in total

1.  Relationship between clinical signs and symptoms of convergence insufficiency.

Authors:  Annette Bade; Mark Boas; Michael Gallaway; G Lynn Mitchell; Mitchell Scheiman; Marjean T Kulp; Susan A Cotter; Michael Rouse
Journal:  Optom Vis Sci       Date:  2013-09       Impact factor: 1.973

2.  Accommodative function in school children with reading difficulties.

Authors:  Catalina Palomo-Alvarez; María C Puell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-28       Impact factor: 3.117

3.  Binocular function in school children with reading difficulties.

Authors:  Catalina Palomo-Alvarez; María C Puell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-04       Impact factor: 3.117

4.  2017 Glenn A. Fry Award Lecture: Establishing an Evidence-based Literature for Vision Therapy - A 25-year Journey.

Authors:  Mitchell M Scheiman
Journal:  Optom Vis Sci       Date:  2018-08       Impact factor: 1.973

5.  The Convergence Insufficiency Neuro-mechanism in Adult Population Study (CINAPS) Randomized Clinical Trial: Design, Methods, and Clinical Data.

Authors:  Tara L Alvarez; Mitchell Scheiman; Elio M Santos; Cristian Morales; Chang Yaramothu; John Vito D'Antonio-Bertagnolli; Bharat B Biswal; Suril Gohel; Xiaobo Li
Journal:  Ophthalmic Epidemiol       Date:  2019-10-22       Impact factor: 1.648

6.  Home-Based Therapy for Symptomatic Convergence Insufficiency in Children: A Randomized Clinical Trial.

Authors: 
Journal:  Optom Vis Sci       Date:  2016-12       Impact factor: 1.973

7.  Randomized clinical trial of treatments for symptomatic convergence insufficiency in children.

Authors: 
Journal:  Arch Ophthalmol       Date:  2008-10

8.  A survey of visual function in an Austrian population of school-age children with reading and writing difficulties.

Authors:  Wolfgang Dusek; Barbara K Pierscionek; Julie F McClelland
Journal:  BMC Ophthalmol       Date:  2010-05-25       Impact factor: 2.209

9.  Validity of the convergence insufficiency symptom survey: a confirmatory study.

Authors:  Michael Rouse; Eric Borsting; G Lynn Mitchell; Susan A Cotter; Marjean Kulp; Mitchell Scheiman; Carmen Barnhardt; Annette Bade; Tomohiko Yamada; Tomohike Yamada
Journal:  Optom Vis Sci       Date:  2009-04       Impact factor: 1.973

10.  Objective Assessment of Vergence after Treatment of Concussion-Related CI: A Pilot Study.

Authors:  Mitchell M Scheiman; Henry Talasan; G Lynn Mitchell; Tara L Alvarez
Journal:  Optom Vis Sci       Date:  2017-01       Impact factor: 1.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.